Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Data show that 1 in 5 men and women worldwide develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
It can take a few weeks before declines in hospitalizations and deaths follow a drop in new COVID-19 cases.
Findings call for implementation of policies and cancer control efforts to reduce alcohol consumption.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
The hep C mortality reduction goal will not be met by any state, according to recent projections.
Women with both conditions are more likely to die prematurely from almost every major cause of death.
Study finds that deaths from cancer accounted for more than 4 million potential years of life lost in 2017
“Some people who are experiencing COVID-19 are more susceptible due to the impacts of air pollution."
Only three states are expected to meet the 2030 goal.
In recent years, deaths from non-small cell lung cancer (NSCLC) have decreased even faster than the decrease in NSCLC incidence.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
However, people with cirrhosis alone were as likely to die as those with both cirrhosis and COVID-19.
Even healthy African-American kids face an increased risk of death within 30 days of undergoing an operation.
In contrast, higher plant protein intake was associated with lower incidence of the disease.
Annual screenings cut mortality rates by 24% in men and 33% in women.
When treated at nonminority hospitals, however, Black patients experienced a 3% decrease in mortality over a 10-year period.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.